ON DEMAND 2024 Midwest Conference - Rapid Sessions - Alcoholic Hepatitis: What is it and what do I do?/Alcohol Use Disorder
CE Information
1.0 contact hour (0.5 pharmacology)Completion Time
1 hour, 5 minutesAvailable Until
December 31, 2025
Navigate
Overview
Clinical Topics
TreatmentAlcoholic Hepatitis: What is it and what do I do? - Annual hospitalizations for alcohol-associated hepatitis increased by more than 20,000 patients in the US during 2019. Despite about a 9% decline in hospital admissions during the pandemic, hospitalization due to acute alcoholic hepatitis increased by roughly 16%. These findings correlate with observed trends of increased excessive alcohol use during the Covid-19 pandemic. This session will focus on reviewing the epidemiology, diagnosis, and management of acute alcoholic hepatitis, and when to refer to a tertiary center for liver transplant evaluation.
Alcohol Use Disorder - This presentation will outline risk factors in the development of AUD, review the DSM-5 criteria required to make a diagnosis, and discuss the mechanism of action and appropriate use of injectable naltrexone when treating AUD in the primary care setting. Standards of care when treating patients with AUD will also be discussed including a review of non-stigmatizing language, samples of history of present illness questions, and screenings for common co-occurring comorbidities and complications. Like other disorders, there are instances when patients may benefit from specialist consultation with addiction medicine or psychiatry. The baseline knowledge reviewed here will help providers treat patients appropriate for primary care.
Learning Objectives
Alcoholic Hepatitis: What is it and what do I do?
Objective: Understand the key aspects of diagnosing and managing acute alcoholic hepatitis, including recognizing when to consider referral for liver transplant evaluation in light of rising hospitalizations linked to increased alcohol use during the Covid-19 pandemic.
Alcohol Use Disorder
Objective: Enhance the proficiency of primary care providers in diagnosing and managing Alcohol Use Disorder (AUD) using DSM-5 criteria, injectable naltrexone, and non-stigmatizing communication, while identifying when referral to addiction specialists is necessary.
Learning Outcome Evaluation: Participants will state one thing they learned from the program and how they will implement it into their practice.
Speakers
Amanda LaMonica-Weier, DNP, MAT, APRN, FNP-BC, CNL is a Family Nurse Practitioner who practices in a primary care setting that specializes in addiction medicine and in shelter-based care. She serves as a Senior ECHO Fellow focusing on opioid use disorder. Dr. LaMonica-Weier is an Assistant Professor at Rush University College of Nursing, with a focus on providing training in the treatment of opioid use disorder and trauma-informed care. She is also working on completing her postdoctoral training as a PMHNP.
Sarah graduated from Vanderbilt University in 2008 with her MSN and became a board certified ACNP in the fall of 2008. She began as a bedside nurse in Miami, FL in the SICU at Jackson Memorial Hospital. In 2009, she began working as an NP in an internal medicine clinic, working with the underserved community in Okeechobee, FL. After moving to Chicago in 2012, she joined the hepatology department at Rush University Medical Center, where she continues to work, managing acute and chronic liver disease as well as pre- and post-liver transplants. She completed her DNP at Rush University College of Nursing and joined the faculty at the College of Nursing at the University of Illinois at Chicago in August 2022 as an adjunct clinical instructor. She is an active member of the Illinois Society of Advanced Practice Nursing, serving on their program committee, as well as a member of the Hepatology Associates Committee of the American Association for Study of Liver Disease.
CE Information
This activity offers 1.0 contact hour (0.5 pharmacology) to attendees.
Accredited by Illinois Nurses Foundation is approved as a provider of nursing continuing professional development by the Montana Nurses Association, an accredited approver with distinction by the American Nurses Credentialing Center’s Commission on Accreditation.
The Illinois Nurses Foundation and the Illinois Society for Advanced Practice Nursing jointly provided this program.
Disclosures
To earn contact hours, learners must watch the entire webinar and submit an evaluation to receive the digital certificate after the session.
There are no relevant financial relationships with ineligible companies for those involved with the ability to control the content of this activity
Activity Content
Registration to this activity includes access to the following supporting materials.
- Alcoholic Hepatitis: What is it and what do I do? (Size: 1.92 MB)
- AUD (Size: 1.16 MB)
Duration: about 1 hour | Quality: HD
5 questions
Access your certificate